On May 7, an article in The New York Times titled “Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses” featured quotes from life sciences counsel Kellie Combs (Washington, DC) on off-label speech in the context of a First Amendment lawsuit filed by Amarin Pharmaceuticals against the Food and Drug Administration. The case concerns the legality of communications between drug companies and physicians regarding the off-label use of drugs.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.